Biosimilar trastuzumab on the PBS - information for health professionals and patients

PBAC

2 December 2019 - A new biosimilar brand of trastuzumab (Kanjinti) has listed on the PBS on 1 December 2019. 

Information about this listing for health professionals and patients can be found on the Biosimilar Awareness Initiative web page.

Read PBS News

Michael Wonder

Posted by:

Michael Wonder